An observational study in Brain Mapping, Deafness and Healthy, sponsored by National Institute of Neurological Disorders and Stroke (NINDS). Completed at 1 site in United States. Per ClinicalTrials.gov, last updated 2008-03-04.
Sponsored by National Institute of Neurological Disorders and Stroke (NINDS) · Observational
The human brain is made up of two halves called hemispheres. Each half of the brain is responsible for processing different kinds of information. Previous neuroimaging studies have shown that both the right and left hemispheres are involved when processing information given in American Sign Language (ASL). However, the study also showed that when processing spoken language, the left hemisphere was mostly involved.
Researchers would like to find out more about how the brain processes American Sign Language (ASL). This study is designed to determine if the right hemisphere is necessary for normal understanding of ASL.
The purpose of this protocol is to determine if the right hemisphere activation associated with perception of American Sign Language (ASL) in deaf subjects and in normal hearing individuals raised by deaf parents (who learned ASL before written English) is necessary for appropriate understanding of ASL.
609 studies on the registry are indexed under Deafness; 111 are open to participants now.
This study's enrollment of 30 is below the median of 80 across 168 observational studies indexed under Deafness.
Browse Deafness studies →National Institute of Neurological Disorders and Stroke (NINDS) is the lead sponsor of 592 studies on the registry; 56 are open to participants now.
Of its 18 completed or terminated interventional studies of FDA-regulated products, 8 (44%) have results posted.
Counted across the registry records on this site, refreshed daily.
Subject age between 18 and 65 years.
Adult hearing offsprings of deaf parents.
Congenitally deaf individuals.
Intact hearing volunteers.
No subjects with personal or family history of seizures or other neurological or demyelinating disorders.
No pregnant women tested after urine pregnancy test.
No subjects with severe coronary disease.
No subjects with metal in the cranium except mouth.
No subjects with intracardiac lines and implanted medication pumps.
No subjects with increased intracranial pressure as evaluated by clinical means.
No subjects with cardiac pacemakers.
No subjects with an intake of neuroleptics.
This study is completed, as verified in Nov 1999. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Institute of Neurological Disorders and Stroke (NINDS)